Healthy subjects: VARILRIX is indicated for active immunisation against varicella of healthy subjects from 9 months of age.
Groups who would particularly benefit from vaccination include: Non-immune adults, especially those in at-risk occupations such as health care workers, teachers and workers in children's day-care centres; Non-immune parents of young children; Non-immune household contacts, both adults and children, of immunocompromised patients with no history of the disease.